Higher Peripheral Blood IFN-Î³-/IL-4+ Th2 Lymphocytes Are Associated with Lower Rate of Relapse in Patients with Lymphoma.

Dehghani, Mehdi; Ramzi, Mani; Kalani, Mehdi; Golmoghaddam, Hossein; Arandi, Nargess

Dehghani, Mehdi; Ramzi, Mani; Kalani, Mehdi; Golmoghaddam, Hossein; Arandi, Nargess.

Afiliación

Dehghani M; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ramzi M; Department of Hematology and Medical Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Kalani M; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Golmoghaddam H; Department of Hematology and Medical Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Arandi N; Department of Immunology, Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Immunol Invest ; 51(2): 452-463, 2022 Feb.

Article en En | MEDLINE | ID: mdl-33148063

Asunto(s)

Interleucina-4; Linfoma; Humanos; Linfoma/diagnóstico; Recurrencia Local de Neoplasia; Células TH1; Células Th2

Palabras clave

Classical Hodgkin lymphoma (cHL); T-helper 2 (Th1); T-helper 2 (Th2); non-Hodgkin lymphoma (NHL); prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Interleucina-4 / Linfoma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Immunol Invest Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google